Followers | 144 |
Posts | 27707 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Sunday, January 17, 2021 6:30:49 AM
https://www.marketbeat.com/instant-alerts/nasdaq-kmda-consensus-analyst-rating-2021-01/
FRIDAY, JANUARY 15, 2021 | MARKETBEAT
Kamada logoAnalysts expect Kamada Ltd. (NASDAQ:KMDA) to announce $33.17 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Kamada's earnings. The lowest sales estimate is $32.40 million and the highest is $33.93 million. Kamada posted sales of $32.07 million in the same quarter last year, which would indicate a positive year over year growth rate of 3.4%. The firm is scheduled to issue its next quarterly earnings results on Wednesday, February 10th.
On average, analysts expect that Kamada will report full-year sales of $134.75 million for the current financial year, with estimates ranging from $134.10 million to $135.64 million. For the next fiscal year, analysts anticipate that the business will report sales of $103.23 million, with estimates ranging from $98.30 million to $106.70 million. Zacks' sales averages are an average based on a survey of research firms that cover Kamada.
Kamada (NASDAQ:KMDA) last released its earnings results on Wednesday, November 11th. The biotechnology company reported $0.15 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.08 by $0.07. The firm had revenue of $35.33 million during the quarter, compared to analyst estimates of $33.49 million. Kamada had a return on equity of 12.89% and a net margin of 15.60%.
Kamada stock opened at $7.23 on Friday. The firm has a market capitalization of $321.88 million, a P/E ratio of 15.06 and a beta of 1.10. The stock has a fifty day moving average price of $6.60 and a 200 day moving average price of $8.00. Kamada has a 52 week low of $4.40 and a 52 week high of $13.33.
A number of large investors have recently made changes to their positions in the business. Ritholtz Wealth Management increased its stake in Kamada by 17.2% during the third quarter. Ritholtz Wealth Management now owns 34,276 shares of the biotechnology company's stock worth $287,000 after acquiring an additional 5,039 shares during the last quarter. Bank of America Corp DE acquired a new stake in Kamada during the second quarter worth about $56,000. O Shaughnessy Asset Management LLC increased its stake in Kamada by 10.0% during the third quarter. O Shaughnessy Asset Management LLC now owns 85,892 shares of the biotechnology company's stock worth $718,000 after acquiring an additional 7,825 shares during the last quarter. Goldman Sachs Group Inc. acquired a new stake in Kamada during the second quarter worth about $84,000. Finally, Jane Street Group LLC increased its stake in Kamada by 61.9% during the third quarter. Jane Street Group LLC now owns 32,090 shares of the biotechnology company's stock worth $268,000 after acquiring an additional 12,268 shares during the last quarter. Institutional investors own 14.25% of the company's stock.
Recent KMDA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2024 11:00:45 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 11:00:29 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 11:00:49 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2024 12:10:12 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/28/2024 12:00:02 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 05:41:57 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 12/28/2023 06:16:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/28/2023 02:30:02 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 12/19/2023 11:00:37 AM
- KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB® • PR Newswire (US) • 12/07/2023 04:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/06/2023 12:00:04 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 11/13/2023 03:04:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 01:00:04 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 12:00:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/08/2023 12:00:31 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2023 11:00:13 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/10/2023 11:30:16 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM